FHA
AKBA icon

Flagship Harbor Advisors’s Akebia Therapeutics AKBA Stock Holding History

Flagship Harbor Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-93
Closed – – 598
2020
Q3 		$0 Sell
93
-796
-90% -$6.99K ﹤0.01% 1905
2020
Q2 		$12K Buy
889
+422
+90% +$4.37K ﹤0.01% 1286
2020
Q1 		$4K Hold
467
– – ﹤0.01% 1440
2019
Q4 		$3K Hold
467
– – ﹤0.01% 1618
2019
Q3 		$1K Hold
467
– – ﹤0.01% 1729
2019
Q2 		$2K Hold
467
– – ﹤0.01% 1659
2019
Q1 		$3K Hold
467
– – ﹤0.01% 1580
2018
Q4 		$2K Buy
467
+45
+11% +$352 ﹤0.01% 1613
2018
Q3 		$4K Buy
422
+325
+335% +$2.91K ﹤0.01% 1724
2018
Q2 		$0 Buy
+97
New +$971 ﹤0.01% 2013

Other funds holding AKBA

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Flagship Harbor Advisors's AKBA Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Akebia Therapeutics (AKBA) in Q4 2020, closing a stake of 93 shares.

Flagship Harbor Advisors first reported a position in AKBA in Q2 2018 and held it in 10 quarters. The position peaked at $12K in Q2 2020. 143 funds tracked by Wall St. Rank hold AKBA as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Akebia Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 93 Akebia Therapeutics shares in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Akebia Therapeutics in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Akebia Therapeutics position peaked at $12K in Q2 2020.
  • 143 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.